Emerging in the landscape of excess body fat management, retatrutide represents a distinct method. Beyond many existing medications, retatrutide works as a twin agonist, simultaneously affecting both glucagon-like peptide-1 (GLP-1) and glucose-responsive insulinotropic substance (GIP) binding sites. The simultaneous activation fosters multiple adva… Read More